[Expression of MMP-3 and TIMP-1 in the endometriosis and the influence of danazol]
Other
OA: closed
CC0
⤵ 29 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the expression of MMP-3 and TIMP-1 in endometriosis and examined the effects of danazol treatment on these markers.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (29)
- Leptin promotes human endometriotic cell migration and invasion by up-regulating MMP-2 through the JAK2/STAT3 signaling pathway 2015
- Endometriosis 2015
- Inhibition of macrophage migration inhibitory factor reduces endometriotic implant size in mice with experimentally induced disease 2011
- Endometriosis 2010
- Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model 2009
- Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells 2007
- The relevancy of the matrix metalloproteinase system to the pathophysiology of endometriosis 2005
- Transcriptional characterizations of differences between eutopic and ectopic endometrium 2005
- Novel targets for the treatment of endometriosis 2004
- Medical management of endometriosis: novel targets and approaches towards the development of future treatment regimes 2003
- Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis 2003
- Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice 2002
- Paracrine regulation of matrix metalloproteinase expression in endometriosis 2002
- Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis 2002
- Experimental endometriosis: the nude mouse as a xenographic host 2002
- Using rats as a research model for the study of endometriosis 2002
- Expression of matrix metalloproteinases in ovarian endometriomas: immunohistochemical study and enzyme immunoassay 2002
- Theories of endometriosis 2001
- Treating endometriosis as an autoimmune disease 2001
- Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium 2001
- Vascular endothelial growth factor and endometriotic angiogenesis 2000
- Is endometriosis an endometrial disease? 2000
- Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium 1999
- The potential role of environmental toxins in the pathophysiology of endometriosis 1999
- Progesterone and transforming growth factor-beta coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis 1999
- Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis 1998
- Novel implications in the development of endometriosis: biphasic effect of macrophage activation on peritoneal tissue expression of tissue inhibitor of metalloproteinase-1 1998
- Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy 1998
- Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions 1997
Source provenance
- europepmc
- last seen: 2026-10-21T06:16:17.486033+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:59:01.426159+00:00
License: CC0
· commercial use OK